1. Prevalence of chronic obstructive pulmonary disease in the global population with HIV: a systematic review and meta-analysis 
Jean Joel Bigna, MD, Angeladine Malaha Kenne, MPH, Serra Lem Asangbeh, MPH, Aurelie T Sibetcheu, MD 
The Lancet Global Health 
Volume 6, Issue 2, Pages e193-e202 (February 2018)
DOI: /S X(17)
Copyright © 2018 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license Terms and Conditions

2. Figure 1 Study selection
The Lancet Global Health 2018 6, e193-e202DOI: ( /S X(17) )
Copyright © 2018 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license Terms and Conditions

3. Figure 2
Random-effects meta-analysis results for prevalence of COPD in the global population with HIV, by diagnostic criteria
LLN=post-bronchodilator FEV1/FVC less than 5% age-dependent lower limit of normal. FEV1=post-bronchodilator forced expiratory volume in 1 s. FVC=forced vital capacity. Fixed-ratio=post-bronchodilator FEV1/FVC less than 0·70. ICD=International Classification of Diseases.
The Lancet Global Health 2018 6, e193-e202DOI: ( /S X(17) )
Copyright © 2018 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license Terms and Conditions

4. Figure 3
Forest plot of the association between exposure to HIV infection and COPD
The Lancet Global Health 2018 6, e193-e202DOI: ( /S X(17) )
Copyright © 2018 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license Terms and Conditions